|
|
Article: STUDY SHOWS NEW INVESTIGATIONAL CORTICOSTEROID SPRAY DECREASES HAY FEVER SYMPTOMS IN YOUNG CHILDREN
- Article from:
- PR Newswire
- Article date:
- March 19, 1996
|
Copyright informationCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW ORLEANS, March 19 /PRNewswire/ -- A new investigational once-daily water-based nasal spray, Nasacort AQ (triamcinolone acetonide), can safely and effectively treat hay fever symptoms in patients as young as six years of age, according to the results of a new study presented today at the 52nd Annual Meeting of the American Academy of Allergy, Asthma, and Immunology.
Hay fever -- also called seasonal allergic rhinitis -- is a common health problem, affecting approximately 22 million Americans of all ages.
The new data showed that Nasacort AQ, a nasally inhaled corticosteroid, relieves hay fever symptoms caused by an allergy to grass pollen in children ranging from six to ...
Related newspaper, magazine, and journal articles:
|